M&A Update – Nov 10

– THS to be acquired by Investindustrial for $22.50 cash per share + CVR, 38.0% premium, $2.9 billion
– MTSR / PFE bumped bid 23.2% to $65.50 cash + CVR worth up to $20.65, received a call from FTC regarding potential risks from proceeding with the proposed Novo Nordisk structure under U.S. antitrust laws
– GTLS / BKR filed China SAMR
– AMWD / MBC received a second request from the FTC
– BRY HSR expires